Palisade Bio Inc. (PALI)
Palisade Bio Receives Health Canada Clearance for Phase 1b Trial of PALI-2108 in Fibrostenotic Crohns Disease (FSCD)
Palisade Bio Receives Health Canada Clearance for Phase 1b Trial of PALI-2108 in Fibrostenotic Crohns Disease (FSCD)
There are no comments here yet...